RNA as a Drug Target: The Next Frontier for Medicinal Chemistry
Author:   John Schneekloth (Yale University) ,  Martin Pettersson (University of Texas at Austin) ,  Raimund Mannhold (University of Dusseldorf, Germany) ,  Helmut Buschmann (Aachen, Germany)
Publisher:   Wiley-VCH Verlag GmbH
ISBN:  

9783527351008


Pages:   416
Publication Date:   07 August 2024
Format:   Hardback
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Our Price $295.95 Quantity:  
Add to Cart

Share |

RNA as a Drug Target: The Next Frontier for Medicinal Chemistry


Add your own review!

Overview

Full Product Details

Author:   John Schneekloth (Yale University) ,  Martin Pettersson (University of Texas at Austin) ,  Raimund Mannhold (University of Dusseldorf, Germany) ,  Helmut Buschmann (Aachen, Germany)
Publisher:   Wiley-VCH Verlag GmbH
Imprint:   Blackwell Verlag GmbH
Dimensions:   Width: 17.00cm , Height: 1.50cm , Length: 24.40cm
Weight:   0.680kg
ISBN:  

9783527351008


ISBN 10:   3527351000
Pages:   416
Publication Date:   07 August 2024
Audience:   Professional and scholarly ,  Professional & Vocational
Format:   Hardback
Publisher's Status:   Active
Availability:   Out of stock   Availability explained
The supplier is temporarily out of stock of this item. It will be ordered for you on backorder and shipped when it becomes available.

Table of Contents

Reviews

Author Information

John Schneekloth, Jr., PhD (Jay), obtained his PhD from the chemistry department of Yale University. Following postdoctoral work at Princeton, Dr. Schneekloth joined the NCI, where his research involves using synthetic chemistry and high throughput chemical biology approaches to develop chemical probes of RNA, with a particular emphasis on targeting RNA with druglike small molecules. Martin Pettersson, PhD, obtained his PhD in Organic Chemistry from the University of Texas at Austin. He is a medical chemistry / drug discovery leader with over 20 years of industrial experience, mainly with Pfizer (co-inventor of Paxlovid). He has then continued as Senior Director of Neuroscience/Pain, Chemistry, at Grünenthal Boston Innovation Hub, and most recently as VP of Drug Discovery at Promedigen in South Korea.

Tab Content 6

Author Website:  

Customer Reviews

Recent Reviews

No review item found!

Add your own review!

Countries Available

All regions
Latest Reading Guide

MRG2025CC

 

Shopping Cart
Your cart is empty
 Shopping cart
Mailing List

 

Sign up now